Independent Attestation Review: Health Resources and Services Administrations Drug Control Accounting for Fiscal Year 2012
Download the complete report
Adobe® Acrobat® is required to read PDF files.
We performed an attestation review of the Health Resources and Services Administration (HRSA) fiscal year (FY) 2012 drug control accounting and accompanying FY 2012 Drug Control Obligation Summary with required table. HRSA reported obligations totaling $17.7 million.
We conducted this review as required by Federal statute (21 U.S.C. § 1704(d)(A)). The Office of National Drug Control Policy's (ONDCP) Circular, Drug Control Accounting, dated May 1, 2007, requires that each year National Drug Control Program agencies submit to the Director of ONDCP an accounting of all funds expended by the agency for National Drug Control Program activities during the previous FY. Section 9 of the circular allows an agency with prior-year drug-related obligations less than $50 million to submit an alternative report to ONDCP consisting of only the required table of prior-year obligations and omitting all other disclosures.
Based on our review, nothing came to our attention that caused us to believe that HRSA's assertions and accompanying table were not fairly stated, in all material respects, based on the Circular.
Copies can also be obtained by contacting the Office of Public Affairs at Public.Affairs@oig.hhs.gov.
Let's start by choosing a topic
Priority recommendations summarized.
FY 2016 Work Plan
OIG projects planned for 2016.
Significant OIG activities in 6-month increments.